dimethyl-fumarate and Amyotrophic-Lateral-Sclerosis

dimethyl-fumarate has been researched along with Amyotrophic-Lateral-Sclerosis* in 1 studies

Other Studies

1 other study(ies) available for dimethyl-fumarate and Amyotrophic-Lateral-Sclerosis

ArticleYear
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis.
    Journal of medicinal chemistry, 2022, 02-10, Volume: 65, Issue:3

    Hybrid compounds containing structural fragments of the Rho kinase inhibitor fasudil and the NRF2 inducers caffeic and ferulic acids were designed with the aid of docking and molecular mechanics studies. Following the synthesis of the compounds using a peptide-coupling methodology, they were characterized for their ROCK2 inhibition, radical scavenging, effects on cell viability (MTT assay), and NRF2 induction (luciferase assay). One of the compounds (

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aged; Amyotrophic Lateral Sclerosis; Cell Line, Tumor; Cell Survival; Coumaric Acids; Female; Free Radical Scavengers; HEK293 Cells; Humans; Kelch-Like ECH-Associated Protein 1; Lymphocytes; Male; Middle Aged; NF-E2-Related Factor 2; Protein Kinase Inhibitors; rho-Associated Kinases

2022